Pear Therapeutics, Inc.: net_income
| Value | {"amount": -30723000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-07-01 – 2022-09-30 |
| Status | current |
| Entity | Pear Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7025a460-1ea0-42e8-a1f1-85ff720af63f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001835567-22-000076 · Open the official SEC filing →Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001835567/net-income/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7025a460-1ea0-42e8-a1f1-85ff720af63f
History
- no predecessors — first report